XBiotech Adds Dr. Peter Libby, Renowned Cardiologist and Research Pioneer in Inflammation and Cardiovascular Disease, to its Corporate Board

NEXT STORY
Equillium Announces Initiation of the EQUIP Phase 1b Clinical Trial of Itolizumab for Patients with Uncontrolled Asthma
PREV STORY
LexaGene’s Beta Prototype Exceeds Expectations During Testing at Massachusetts Veterinary Referral Hospital
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Accelerate Diagnostics Welcomes Dr. Charles Watts to its Board of Directors

TUCSON, Ariz., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced the ...

author_avatar
NASDAQ Market News

Cytokinetics to Host R&D Day on October 16, 2018

SOUTH SAN FRANCISCO, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK), ...

author_avatar
NASDAQ Market News

VBL Therapeutics Announces Publication of Positive New Data on its Lecinoxoid Drug Candidates for the Treatment of Renal Fibrosis

These data, together with positive preclinical NASH data previously presented, support the potential of ...

author_avatar
NASDAQ Market News